Osaic Holdings’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Osaic Holdings’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-43	Closed	-$42	–	7536
2023 Q3	$42	Hold	43	–	–	﹤0.01%	7285
2023 Q2	$30	Hold	43	–	–	﹤0.01%	7353
2023 Q1	$28	Hold	43	–	–	﹤0.01%	7411
2022 Q4	$0	Hold	43	–	–	﹤0.01%	7547
2022 Q3	$0	Buy	+43	New	+$124	﹤0.01%	7613
2021 Q4	–	Sell	-200	Closed	-$6K	–	7671
2021 Q3	$6K	Buy	+200	New	+$6.49K	﹤0.01%	6485
2020 Q4	–	Sell	-58	Closed	-$2K	–	6655
2020 Q3	$2K	Buy	+58	New	+$2.28K	﹤0.01%	5917

Other funds holding FRTX

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Osaic Holdings's FRTX Position: Q4 2023 in Review

Osaic Holdings sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2023, closing a stake of 43 shares — an estimated $42 sold.

Osaic Holdings first reported a position in FRTX in Q3 2020 and held it in 7 quarters. The position peaked at $6K in Q3 2021. 1 fund tracked by Wall St. Rank holds FRTX as of Q4 2023.

Osaic Holdings reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Osaic Holdings sold 43 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $42.
Osaic Holdings first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
Osaic Holdings's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $6K in Q3 2021.
1 fund tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Osaic Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.